uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Molecular and Morphological Pathology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Radiology, Oncology and Radiation Science, Oncology.
Show others and affiliations
2013 (English)In: BMC Cancer, ISSN 1471-2407, Vol. 13, 512- p.Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Different molecular subtypes of breast cancer have been identified based on gene expression profiling. Treatment suggestions based on an approximation of these subtypes by immunohistochemical criteria have been published by the St Gallen international expert consensus panel. Ductal carcinoma in situ (DCIS) can be classified into the same molecular subtypes. Our aim was to study the relation between these newly defined subtypes and prognosis in DCIS.

METHODS: TMA including 458 women from a population-based cohort with DCIS diagnosed 1986-2004 was used. Stainings for ER, PR, HER2 and Ki67 were used to classify the surrogate molecular subtypes according to the St Gallen criteria from 2011. The associations with prognosis were examined using Kaplan-Meier analyses and Cox proportional hazards regression models.

RESULTS: Surrogate molecular subtyping could be done in 381 cases. Mean follow up was 164 months. Of the classified DCIS 186 were Luminal A (48.8%), 33 Luminal B/HER2- (8.7%), 74 Luminal B/HER2+ (17.4%), 61 HER2+/ER- (16.0%) and 27 Triple Negative (7.1%). One hundred and two women had a local recurrence of which 58 were invasive. Twenty-two women had generalised disease, 8 without a prior local recurrence. We could not find a prognostic significance of the molecular subtypes other than a higher risk of developing breast cancer after more than 10 years of follow-up among women with a Triple Negative DCIS (OR 3.2; 95% CI 1.1-9.8).

CONCLUSIONS: The results from this large population-based cohort, with long-term follow up failed to demonstrate a prognostic value for the surrogate molecular subtyping of DCIS using the St Gallen criteria up to ten years after diagnosis. More than ten years after diagnosis Triple Negative DCIS had an elevated risk of recurrence.

Place, publisher, year, edition, pages
2013. Vol. 13, 512- p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-215823DOI: 10.1186/1471-2407-13-512ISI: 000329025500004PubMedID: 24171825OAI: oai:DiVA.org:uu-215823DiVA: diva2:688586
Available from: 2014-01-17 Created: 2014-01-17 Last updated: 2014-01-27Bibliographically approved

Open Access in DiVA

fulltext(1247 kB)66 downloads
File information
File name FULLTEXT01.pdfFile size 1247 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Amini, Rose-MarieFjällskog, Marie-LouiseLindman, HenrikWärnberg, Fredrik
By organisation
Department of Surgical SciencesMolecular and Morphological PathologyOncologyEndocrine Surgery
In the same journal
BMC Cancer
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 66 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 324 hits
ReferencesLink to record
Permanent link

Direct link